- Home
- GPCR vs CCU Comparison
GPCR vs CCU Comparison
Compare GPCR & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- CCU
- Stock Information
- Founded
- GPCR 2016
- CCU 1850
- Country
- GPCR United States
- CCU Chile
- Employees
- GPCR N/A
- CCU N/A
- Industry
- GPCR
- CCU Beverages (Production/Distribution)
- Sector
- GPCR
- CCU Consumer Staples
- Exchange
- GPCR Nasdaq
- CCU Nasdaq
- Market Cap
- GPCR 1.8B
- CCU 2.0B
- IPO Year
- GPCR 2023
- CCU 1992
- Fundamental
- Price
- GPCR $27.03
- CCU $11.82
- Analyst Decision
- GPCR Buy
- CCU Strong Sell
- Analyst Count
- GPCR 6
- CCU 2
- Target Price
- GPCR $85.67
- CCU $9.70
- AVG Volume (30 Days)
- GPCR 797.2K
- CCU 193.1K
- Earning Date
- GPCR 11-13-2024
- CCU 11-06-2024
- Dividend Yield
- GPCR N/A
- CCU 1.51%
- EPS Growth
- GPCR N/A
- CCU 16.02
- EPS
- GPCR N/A
- CCU 0.39
- Revenue
- GPCR N/A
- CCU $2,795,960,314.00
- Revenue This Year
- GPCR N/A
- CCU $6.59
- Revenue Next Year
- GPCR N/A
- CCU $5.74
- P/E Ratio
- GPCR N/A
- CCU $15.00
- Revenue Growth
- GPCR N/A
- CCU N/A
- 52 Week Low
- GPCR $29.48
- CCU $10.00
- 52 Week High
- GPCR $62.74
- CCU $13.74
- Technical
- Relative Strength Index (RSI)
- GPCR 35.94
- CCU 50.99
- Support Level
- GPCR $30.81
- CCU $11.34
- Resistance Level
- GPCR $36.42
- CCU $11.96
- Average True Range (ATR)
- GPCR 2.10
- CCU 0.20
- MACD
- GPCR -0.15
- CCU -0.01
- Stochastic Oscillator
- GPCR 25.07
- CCU 16.42
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.